Items where authors include "Wilcox, M."

Article

Woods, B. orcid.org/0000-0002-7669-9415, Kearns, B., Schmitt, L. et al. (15 more authors) (2025) Assessing the value of new antimicrobials: evaluations of cefiderocol and ceftazidime-avibactam to inform delinked payments by the NHS in England. Applied Health Economics and Health Policy, 23 (1). pp. 5-17. ISSN 1175-5652

Freeman, J., Viprey, V. orcid.org/0000-0001-6463-7092, Ewin, D. et al. (10 more authors) (2024) Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance, 6 (4). dlae112. ISSN 2632-1823

Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347

Normington, C., Moura, I. orcid.org/0000-0002-3019-7196, Byrant, J. et al. (4 more authors) (2022) Sessile Clostridioides difficilecontribute towards recurrent C. difficileinfection. Access Microbiology, 4 (5). ISSN 2516-8290

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Proceedings Paper

Beauchemin, N., Halvorsen, E., Hicks, N. et al. (20 more authors) (2025) Sa1770: CHARACTERIZATION OF IBD MICROBIOMES IN MODELS OF MICROBIOME DISRUPTION AND INFLAMMATION TO EVALUATE CANDIDATE BIOMARKERS FOR PATIENT SELECTION. In: Gastroenterology. DDW 2025, 03-06 May 2025, San Diego, USA. Elsevier , S-523-S-523.